Summary
Eighty-eight adult male Sprague-Dawley rats were given a diet with either (a) 0.5% Ca and 0.6% P or (b) 0.01% Ca and 0.6% P. Osteopenia was created by adding prednisolone to the diet. The prophylactic effect of oral 1,25(OH)2D3 on the osteopenia was studied. It was found that prednisolone osteopenia in the rat was associated with defective Ca absorption. By giving an oral dose of 1,25(OH)2D3, it was possible to maintain normal Ca absorption during prednisolone treatment and to prevent the bone loss. No significant hypercalcemia or any kidney calcifications were seen. These results are in contrast to earlier findings, in which subcutaneous administration of 1,25(OH)2D3 failed to prevent prednisolone osteopenia because of its tendency to increase bone resorption.
Similar content being viewed by others
References
Kimberg DV, Bacry RD, Gershon EE, Graudusius RT (1971) Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest 50:1209–1321
Gallagher JC, Aaron J, Horsman A, Wilkinson R, Nordin BEC (1973) Corticosteroid osteoporosis. J Clin Endocrinol Metab 2:355–368
Favus MJ, Walling MW, Kimberg DV (1973). Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone treated rats. J Clin Invest 52:1680–1685
Lindgren JU, Merchant CR, DeLuca HF (1981). The effect of 1,25(OH)2D3 on osteopenia induced by prednisolone in adult rats. To be published
Martin DL, DeLuca HF (1969). Influence of sodium on calcium transport by the rat small intestine. Am J Physiol 261:1251–1359
Storey E (1960). Bone changes associated with cortisone administration in the rat. Br J Exp Pathol 41:207–213
O'Regan S, Chesney RW, Hamstra A, Eisman JA, O'Gorman AM, DeLuca HF (1979). Reduced serum 1,25(OH)2D3 levels in prednisolone treated adolescents with systemic lupus erythematosus. Acta Pediatr Scand 68:109–111
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindgren, J.J., DeLuca, H.F. Oral 1,25(OH)2D3: An effective prophylactic treatment for glucocorticoid osteopenia in rats. Calcif Tissue Int 35, 107–110 (1983). https://doi.org/10.1007/BF02405014
Issue Date:
DOI: https://doi.org/10.1007/BF02405014